An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma

Ravi Vij; Michael Wang; Jonathan L. Kaufman; Sagar Lonial; Andrzej J. Jakubowiak; A. Keith Stewart; Vishal Kukreti; Sundar Jagannath; Kevin T. McDonagh; Melissa Alsina; Nizar J. Bahlis; Frederic J. Reu; Nashat Y. Gabrail; Andrew Belch; Jeffrey V. Matous; Peter Lee; Peter Rosen; Michael Sebag; David H. Vesole; Lori A. Kunkel; Sandra M. Wear; Alvin F. Wong; Robert Z. Orlowski; David S. Siegel

doi:10.1182/BLOOD-2012-03-414359

An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma

Ravi Vij
, Michael Wang
, Jonathan L. Kaufman
, Sagar Lonial
, Andrzej J. Jakubowiak
, A. Keith Stewart
, Vishal Kukreti
, Sundar Jagannath
, Kevin T. McDonagh
, Melissa Alsina
, Nizar J. Bahlis
, Frederic J. Reu
, Nashat Y. Gabrail
, Andrew Belch
, Jeffrey V. Matous
, Peter Lee
, Peter Rosen
, Michael Sebag
, David H. Vesole
, Lori A. Kunkel

Sandra M. Wear, Alvin F. Wong, Robert Z. Orlowski, David S. Siegel

Washington University in St. Louis
University of Texas MD Anderson Cancer Center
Emory University
University of Michigan
Mayo Clinic
University of Toronto
Mount Sinai Hospital
University of Kentucky
University of South Florida
University of Calgary
Cleveland Clinic
Gabrail Cancer Center
University of Alberta
Colorado Blood Cancer Institute
Tower Cancer Research Foundation
Providence Saint Joseph Medical Center
Royal Victoria Hospital, Montreal, QC;
John Theurer Cancer Center at Hackensack University, Hackensack, NJ;
Independent Consultant
Multiple Myeloma Research Consortium
Onyx Pharmaceuticals

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	119
Issue number	24
DOIs	https://doi.org/10.1182/BLOOD-2012-03-414359
State	Published - Jun 14 2012
Externally published	Yes

Disciplines

Medicine and Health Sciences
Gastroenterology
Surgery
Internal Medicine

Access to Document

10.1182/BLOOD-2012-03-414359License: Unspecified

Cite this

Vij, R., Wang, M., Kaufman, J. L., Lonial, S., Jakubowiak, A. J., Stewart, A. K., Kukreti, V., Jagannath, S., McDonagh, K. T., Alsina, M., Bahlis, N. J., Reu, F. J., Gabrail, N. Y., Belch, A., Matous, J. V., Lee, P., Rosen, P., Sebag, M., Vesole, D. H., ... Siegel, D. S. (2012). An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma. Blood, 119(24). https://doi.org/10.1182/BLOOD-2012-03-414359

Vij, R, Wang, M, Kaufman, JL, Lonial, S, Jakubowiak, AJ, Stewart, AK, Kukreti, V, Jagannath, S, McDonagh, KT, Alsina, M, Bahlis, NJ, Reu, FJ, Gabrail, NY, Belch, A, Matous, JV, Lee, P, Rosen, P, Sebag, M, Vesole, DH, Kunkel, LA, Wear, SM, Wong, AF, Orlowski, RZ & Siegel, DS 2012, 'An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma', Blood, vol. 119, no. 24. https://doi.org/10.1182/BLOOD-2012-03-414359

@article{9a710455a89243f1bce91b7ca45ff740,

title = "An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma",

author = "Ravi Vij and Michael Wang and Kaufman, \{Jonathan L.\} and Sagar Lonial and Jakubowiak, \{Andrzej J.\} and Stewart, \{A. Keith\} and Vishal Kukreti and Sundar Jagannath and McDonagh, \{Kevin T.\} and Melissa Alsina and Bahlis, \{Nizar J.\} and Reu, \{Frederic J.\} and Gabrail, \{Nashat Y.\} and Andrew Belch and Matous, \{Jeffrey V.\} and Peter Lee and Peter Rosen and Michael Sebag and Vesole, \{David H.\} and Kunkel, \{Lori A.\} and Wear, \{Sandra M.\} and Wong, \{Alvin F.\} and Orlowski, \{Robert Z.\} and Siegel, \{David S.\}",

note = "Ravi Vij, Michael Wang, Jonathan L. Kaufman, Sagar Lonial, Andrzej J. Jakubowiak, A. Keith Stewart, Vishal Kukreti, Sundar Jagannath, Kevin T. McDonagh, Melissa Alsina, Nizar J. Bahlis, Frederic J. Reu, Nashat Y. Gabrail, Andrew Belch, Jeffrey V. Matous, Peter Lee, Peter Rosen, Michael Sebag, David H. Vesole, Lori A.",

year = "2012",

month = jun,

day = "14",

doi = "10.1182/BLOOD-2012-03-414359",

language = "American English",

volume = "119",

journal = "Blood",

publisher = "American Society of Hematology",

number = "24",

}

TY - JOUR

T1 - An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma

AU - Vij, Ravi

AU - Wang, Michael

AU - Kaufman, Jonathan L.

AU - Lonial, Sagar

AU - Jakubowiak, Andrzej J.

AU - Stewart, A. Keith

AU - Kukreti, Vishal

AU - Jagannath, Sundar

AU - McDonagh, Kevin T.

AU - Alsina, Melissa

AU - Bahlis, Nizar J.

AU - Reu, Frederic J.

AU - Gabrail, Nashat Y.

AU - Belch, Andrew

AU - Matous, Jeffrey V.

AU - Lee, Peter

AU - Rosen, Peter

AU - Sebag, Michael

AU - Vesole, David H.

AU - Kunkel, Lori A.

AU - Wear, Sandra M.

AU - Wong, Alvin F.

AU - Orlowski, Robert Z.

AU - Siegel, David S.

N1 - Ravi Vij, Michael Wang, Jonathan L. Kaufman, Sagar Lonial, Andrzej J. Jakubowiak, A. Keith Stewart, Vishal Kukreti, Sundar Jagannath, Kevin T. McDonagh, Melissa Alsina, Nizar J. Bahlis, Frederic J. Reu, Nashat Y. Gabrail, Andrew Belch, Jeffrey V. Matous, Peter Lee, Peter Rosen, Michael Sebag, David H. Vesole, Lori A.

PY - 2012/6/14

Y1 - 2012/6/14

UR - http://www.bloodjournal.org/content/bloodjournal/119/24/5661.full.pdf

U2 - 10.1182/BLOOD-2012-03-414359

DO - 10.1182/BLOOD-2012-03-414359

M3 - Article

VL - 119

JO - Blood

JF - Blood

IS - 24

ER -

An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma

Disciplines

Access to Document

Other files and links

Cite this